AGCT1531 - A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Protocol: 
AAAR4300
Phase: 
III

AGCT1531 - A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Are you Eligible? (Inclusion Criteria)

-Subjects may be up to 49 years of age at the time of study entry.
-Patients must have been diagnosed with a primary extracranial germ cell tumor.
-Subjects must be considered low risk or standard risk to participate.
-Patients must also meet all eligibility criteria as outlined in the study protocol.